Susquehanna International Group
FBIO icon

Susquehanna International Group’s Fortress Biotech FBIO Stock Holding History

Susquehanna International Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793K Buy
284,300
+61,500
+28% +$209K ﹤0.01% 8497
2025
Q4 		$815K Buy
222,800
+148,500
+200% +$423K ﹤0.01% 7631
2025
Q3 		$275K Buy
74,300
+33,400
+82% +$84.4K ﹤0.01% 10312
2025
Q2 		$76.1K Buy
40,900
+19,600
+92% +$33.9K ﹤0.01% 11935
2025
Q1 		$33.2K Buy
+21,300
New +$37.5K ﹤0.01% 11982
2024
Q4 		– Sell
-12,800
Closed -$18.6K – 12484
2024
Q3 		$18.6K Sell
12,800
-12,200
-49% -$23.2K ﹤0.01% 11641
2024
Q2 		$42.8K Buy
25,000
+15,000
+150% +$27.2K ﹤0.01% 11473
2024
Q1 		$20K Sell
10,000
-6,300
-39% -$12.5K ﹤0.01% 11818
2023
Q4 		$49.1K Buy
+16,300
New +$43.1K ﹤0.01% 11723
2022
Q2 		– Sell
-4,707
Closed -$96K – 13185
2022
Q1 		$96K Sell
4,707
-3,473
-42% -$95.1K ﹤0.01% 11942
2021
Q4 		$307K Buy
8,180
+2,867
+54% +$128K ﹤0.01% 10449
2021
Q3 		$257K Buy
5,313
+1,646
+45% +$80.3K ﹤0.01% 10952
2021
Q2 		$196K Buy
+3,667
New +$221K ﹤0.01% 11623
2019
Q2 		– Sell
-827
Closed -$22K – 10365
2019
Q1 		$22K Buy
+827
New +$21.7K ﹤0.01% 8581
2016
Q4 		– Sell
-3,247
Closed -$145K – 9724
2016
Q3 		$145K Buy
+3,247
New +$138K ﹤0.01% 7790
2015
Q3 		– Sell
-887
Closed -$45K – 9738
2015
Q2 		$45K Sell
887
-946
-52% -$48.5K ﹤0.01% 9896
2015
Q1 		$106K Sell
1,833
-3,667
-67% -$153K ﹤0.01% 8945
2014
Q4 		$201K Buy
5,500
+4,347
+377% +$128K ﹤0.01% 8807
2014
Q3 		$36K Sell
1,153
-1,760
-60% -$46.7K ﹤0.01% 9273
2014
Q2 		$75K Sell
2,913
-87
-3% -$2.29K ﹤0.01% 9513
2014
Q1 		$89K Sell
3,000
-3,027
-50% -$118K ﹤0.01% 8595
2013
Q4 		$238K Sell
6,027
-6,820
-53% -$263K ﹤0.01% 7978
2013
Q3 		$1.35M Buy
12,847
+9,980
+348% +$1.22M ﹤0.01% 4787
2013
Q2 		$370K Buy
+2,867
New +$423K ﹤0.01% 6483

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's FBIO Position: Q1 2026 in Review

Susquehanna International Group reduced its Fortress Biotech (FBIO) stake by 8.3% in Q1 2026, selling an estimated $64.7K and leaving 210,745 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #9242.

Susquehanna International Group first reported a position in FBIO in Q2 2013 and has held it in 31 quarters since. The position peaked at $1.32M in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Susquehanna International Group held 210,745 shares of Fortress Biotech worth $588K as of Q1 2026.
  • Susquehanna International Group sold 19,032 Fortress Biotech shares in Q1 2026, an estimated $64.7K.
  • Fortress Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9242 holding.
  • Susquehanna International Group first reported a position in Fortress Biotech in Q2 2013 and has held it in 31 quarters since.
  • Susquehanna International Group's Fortress Biotech position peaked at $1.32M in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.